We’re excited to be exhibiting on Feb 7-10th at the #IO360nyc ! Come and meet with our team at booth #18 𝑾𝒆’𝒓𝒆 𝒍𝒐𝒐𝒌𝒊𝒏𝒈 𝒇𝒐𝒓𝒘𝒂𝒓𝒅 𝒕𝒐 𝒔𝒆𝒆 𝒚𝒐𝒖 𝒕𝒉𝒆𝒓𝒆! #Oncimmune #ImmunoINSIGHTS #biomarkers #cancerimmunotherapy #clinicaltrials #precisiononcology

Nice review on the interplay of immune #checkpointinhibitors ICI therapies #toxicities #cancer. #BCells & #antibodies against autologous antigens (#autoantibodies) advances as emerging #biomarkers to predict immune-related #adverseevents #irAEs bit.ly/3Ylj4dH

Are you attending #IO360nyc ? Make sure to meet our team at booth 18. Learn more about the #ImmunoINSIGHTS platform and how it provides relevant immune #biomarker insights for your clinical programs. #celltherapy #cancerresearch #clinicaltrials #immunooncology

BIVDA member @OncimmuneECDT received a Queen’s Award for Enterprise in Innovation 2022 by Sir John Peace, the Lord-Lieutenant of Nottinghamshire, today. What a great achievement, congratulations from all at BIVDA!

ABHI member @OncimmuneECDT received a Queen’s Award for Enterprise in Innovation 2022 by Sir John Peace, the Lord-Lieutenant of Nottinghamshire, today. What a great achievement, congratulations from all at ABHI!

We're thrilled to have received the @TheQueensAwards for Enterprise in Innovation 2022 awarded by Sir John Peace, the Nottinghamshire Lieutenancy at our Nottingham laboratories! Thanks to all our staff who have made this great achievement possible! LordMayorOfNottm #TeamOncimmune

#FridayReads This review on T cell response in #autoimmunity and #cancer highlights interplay from these two diseases and how they can provide answers to improve the application, efficacy, and management of #immunotherapies #biomarkers #autoantibodies bit.ly/3lIJOXz

#Fridayreads Evidence that elevated #IFNα levels act directly on B cells to facilitate #autoantibody production & further highlight the importance of IFN signaling as a potential therapeutic target in #Systemiclupuserythematosus #SLE bit.ly/3J8Nuv0 #ImmunoINSIGHTS

Today we celebrate the achievements of women who innovate, lead, and inspire! Happy #InternationalWomenDay to all our colleagues, inspiring women working to support our mission, to improve the understanding of the #immunesystem and advance #precisionmedicine. #WomenInSTEM

Oncimmune is attending #BioEuropeSpring conference March 20-23 in Basel! Make sure to take the opportunity to connect with Mike Fisher PhD VP and Head of Business Development. 👉 bit.ly/3ZTXL3z #ImmunoINSIGHTS #Autoantibodies #Biomarkers #Biotechnology

#FridayRead #autoantibodies in patients infected with #SARSCoV2 Anti-chemokine autoantibodies are likely to be associated with better outcome following SARS-CoV-2 infection compared to patients with #longCOVID. go.nature.com/41X3ebX

#Fridayread Adrenal insufficiency is an endocrine immune-related adverse event that can be induced by #checkpointinhibitors causing deficiency of adrenal cortisol production. This review highlights mechanisms & #autoantibodies associated wt AI. bit.ly/3YSQaS5

Attending #BioEuropeSpring in #Basel ? Connect with Mike Fisher PhD our VP and Head of business development to learn more how #ImmunoINSIGHTS autoantibody biomarker discovery platform. bit.ly/3HOKaDg #Autoantibodies #Biomarkers #Biotechnology

To all our new followers, a warm welcome! At Oncimmune our team comes together to provide a better understanding of the immune response to therapies, improve clinical trial outcomes & support the development of safer treatments for patients. bit.ly/3fGnzyy

Discover ImmunoINSIGHTS™, the leading biomarker discovery platform that works to detect novel #autoantibody signatures for immunooncology, autoimmune and infectious diseases. bit.ly/3eJmENh #ImmunoINSIGHTS #Biomarkers #ImmuneBiomarkers #Autoantibodies

#Didyouknow #Autoantibodies can be found in clinically & immunologically opposing diseases, such as #autoimmune diseases & #cancer. Often referred to as anti-tumor #antibodies, or tumor-associated antibodies, they are implicated heavily in cancer #immunity bit.ly/3GRjUc6

Oncimmune is thrilled to participate and meet customers at the upcoming 2023 American Society of Clinical Oncology #ASCO23 Annual Meeting, to be held in-person on June 2-6, 2023, in Chicago, Illinois. Visit us at booth 18156! bit.ly/3oNSJse #ImmunoINSIGHTS

To all our new followers, a warm welcome! At Oncimmune our team comes together to provide a better understanding of the immune response to therapies, improve clinical trial outcomes & support the development of safer treatments for patients. bit.ly/3fGnzyy

Discover ImmunoINSIGHTS™, the leading biomarker discovery platform that works to detect novel #autoantibody signatures for immunooncology, autoimmune and infectious diseases. bit.ly/3eJmENh #ImmunoINSIGHTS #Biomarkers #ImmuneBiomarkers #Autoantibodies

#Didyouknow #Autoantibodies can be found in clinically & immunologically opposing diseases, such as #autoimmune diseases & #cancer. Often referred to as anti-tumor #antibodies, or tumor-associated antibodies, they are implicated heavily in cancer #immunity bit.ly/3GRjUc6